Category Archives: Cancer and neoplasms

Specialty

Myeloproliferative neoplasms (MPNs) are a cancer that occurs when the bone marrow makes too many red or white blood cells or platelets. While the group of cancers is rare, researchers, clinicians and patient advocates are continuously making strides for blood diseases — leading to better outcomes and quality of life for patients who have them. […]

Specialty

Abstract Chronic inflammation is integral to the development of esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), although the latter has not been associated with reflux esophagitis. The L2-IL-1β transgenic mice, expressing human interleukin (IL)-1β in the oral, esophageal and forestomach squamous epithelia feature chronic inflammation and a stepwise development of Barrett’s esophagus-like metaplasia, […]

For patients hospitalized for a wide range of medical conditions, type 2 diabetes (T2D) was found to be associated with an increased risk of hospital bed-days, according to a study published today in PLoS Medicine. One group that saw a particularly higher risk of hospital bed-days was patients who received a T2D diagnosis before the […]

A new study has raised questions about healthcare preparedness for treating patients with hematologic neoplasms during major disruptive events, such as the COVID-19 pandemic. Researchers found that the COVID-19 pandemic caused significant changes in visit rates among patients with hematologic neoplasms from 2020 to 2021. A retrospective observational study, which was published in JAMA, found […]

Specialty

The following is a summary of “Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study,” published in the June 2023 issue of Diabetes and Endocrinology by Medas et al. Since its emergence in early 2020, the COVID-19 pandemic has diverted resources from non-urgent and elective procedures, […]

Specialty

Specialty